Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dapagliflozin Tablets

Approval Number

国药准字H20234463

Company阿斯利康药业（中国）有限公司

Registration Date

November 7, 2023

Drug Information

Generic Name

达格列净片

Dosage Form

片剂

Strength

10mg (以C₂₁H₂₅ClO₆计)

Drug Type

化学药品

Registration Date

November 7, 2023

Company Information

Applicant Company

Company Name阿斯利康药业（中国）有限公司

Company Address

泰州市药城大道88号

Manufacturing Company

Company Name阿斯利康药业（中国）有限公司

Company Address

泰州市药城大道88号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy